• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小儿脑肿瘤中的异常组蛋白修饰

Aberrant histone modifications in pediatric brain tumors.

作者信息

Hamanishi Erin T, Dang Derek, Venneti Sriram

机构信息

Division of Pediatric Hematology, Oncology and Bone Marrow Transplant, Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, United States.

Department of Pediatrics, University of Michigan Medical School, Ann Arbor, MI, United States.

出版信息

Front Oncol. 2025 Jun 10;15:1587157. doi: 10.3389/fonc.2025.1587157. eCollection 2025.

DOI:10.3389/fonc.2025.1587157
PMID:40556679
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12185454/
Abstract

Epigenetic modifications, particularly histone post-translational modifications (PTMs), are central to pediatric brain tumor pathogenesis, impacting chromatin structure, gene expression, and genomic stability. Disruptions in histone PTMs, especially lysine methylation and acetylation, arising due to histone mutations or aberrant enzyme modulation are critical drivers of oncogenesis. Lysine methylation, catalyzed by histone methyltransferases (KMTs), modulates chromatin interactions and gene expression through activation or repression, depending on the methylation state and the specific histone residue. Key enzymes, including histone methyltransferases and demethylases, and associated proteins exemplify the functions of writers, readers, and erasers in maintaining histone modification balance. Similarly, histone acetylation, a dynamic process regulated by histone acetyltransferases (HATs) and histone deacetylases (HDACs), plays a crucial role in pediatric brain tumors. Alterations in these components lead to aberrant gene expression and tumorigenesis. Understanding these disrupted processes offers potential for targeted therapies to rewire oncogenic chromatin states and potentially improve patient outcomes.

摘要

表观遗传修饰,尤其是组蛋白翻译后修饰(PTMs),在儿童脑肿瘤发病机制中至关重要,影响着染色质结构、基因表达和基因组稳定性。由于组蛋白突变或异常的酶调节而导致的组蛋白PTMs紊乱,尤其是赖氨酸甲基化和乙酰化,是肿瘤发生的关键驱动因素。由组蛋白甲基转移酶(KMTs)催化的赖氨酸甲基化,根据甲基化状态和特定的组蛋白残基,通过激活或抑制来调节染色质相互作用和基因表达。包括组蛋白甲基转移酶和去甲基酶在内的关键酶以及相关蛋白,体现了“书写者”“阅读者”和“擦除者”在维持组蛋白修饰平衡中的功能。同样,组蛋白乙酰化是一个由组蛋白乙酰转移酶(HATs)和组蛋白去乙酰化酶(HDACs)调节的动态过程,在儿童脑肿瘤中起关键作用。这些成分的改变会导致异常的基因表达和肿瘤发生。了解这些被破坏的过程为靶向治疗提供了潜力,以重塑致癌染色质状态并可能改善患者预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8ae/12185454/c1bbe6bb1b4b/fonc-15-1587157-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8ae/12185454/de504e791b66/fonc-15-1587157-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8ae/12185454/c1bbe6bb1b4b/fonc-15-1587157-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8ae/12185454/de504e791b66/fonc-15-1587157-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a8ae/12185454/c1bbe6bb1b4b/fonc-15-1587157-g002.jpg

相似文献

1
Aberrant histone modifications in pediatric brain tumors.小儿脑肿瘤中的异常组蛋白修饰
Front Oncol. 2025 Jun 10;15:1587157. doi: 10.3389/fonc.2025.1587157. eCollection 2025.
2
Modulating Cognition-Linked Histone Acetyltransferases (HATs) as a Therapeutic Strategy for Neurodegenerative Diseases: Recent Advances and Future Trends.调节与认知相关的组蛋白乙酰转移酶(HATs)作为神经退行性疾病的治疗策略:最新进展与未来趋势
Cells. 2025 Jun 10;14(12):873. doi: 10.3390/cells14120873.
3
The Role of Epigenetics in Manganese Neurotoxicity: An Update with a Focus on Non-Coding RNAs and Histone Modifications.表观遗传学在锰神经毒性中的作用:聚焦于非编码RNA和组蛋白修饰的最新进展
Neurochem Res. 2025 Jun 11;50(3):195. doi: 10.1007/s11064-025-04456-1.
4
Unlocking the potential of histone deacetylase inhibitors in combatting age-related retinal degenerative diseases.释放组蛋白去乙酰化酶抑制剂在对抗年龄相关性视网膜退行性疾病方面的潜力。
Ageing Res Rev. 2025 Aug;110:102788. doi: 10.1016/j.arr.2025.102788. Epub 2025 May 31.
5
Contribution of histone deacetylases (HDACs) to the regulation of histone and non-histone proteins: implications for fibrotic diseases.组蛋白去乙酰化酶(HDACs)对组蛋白和非组蛋白蛋白质调控的贡献:对纤维化疾病的影响。
BMB Rep. 2025 Jul 10.
6
Role of the histone variant H2A.Z.1 in memory, transcription, and alternative splicing is mediated by lysine modification.组蛋白变体 H2A.Z.1 在记忆、转录和选择性剪接中的作用是由赖氨酸修饰介导的。
Neuropsychopharmacology. 2024 Jul;49(8):1285-1295. doi: 10.1038/s41386-024-01817-2. Epub 2024 Feb 16.
7
Histone Acetylation in Central and Peripheral Nervous System Injuries and Regeneration: Epigenetic Dynamics and Therapeutic Perspectives.中枢和外周神经系统损伤与再生中的组蛋白乙酰化:表观遗传动力学与治疗前景
Int J Mol Sci. 2025 Jun 29;26(13):6277. doi: 10.3390/ijms26136277.
8
A systematic review of epigenetic interplay in kidney diseases: Crosstalk between long noncoding RNAs and methylation, acetylation of chromatin and histone.系统综述肾脏疾病中的表观遗传相互作用:长非编码 RNA 与染色质甲基化、乙酰化和组蛋白之间的串扰。
Biomed Pharmacother. 2024 Jul;176:116922. doi: 10.1016/j.biopha.2024.116922. Epub 2024 Jun 12.
9
Human iPSC-Cardiomyocytes as an Experimental Model to Study Epigenetic Modifiers of Electrophysiology.人诱导多能干细胞心肌细胞作为研究电生理表观遗传修饰剂的实验模型。
Cells. 2022 Jan 7;11(2):200. doi: 10.3390/cells11020200.
10
High-throughput epigenetic profiling immunoassays for accelerated disease research and clinical development.用于加速疾病研究和临床开发的高通量表观遗传学分析免疫测定法。
J Biol Chem. 2025 Jun 7;301(7):110352. doi: 10.1016/j.jbc.2025.110352.

本文引用的文献

1
Histone bivalency in CNS development.中枢神经系统发育中的组蛋白双价性。
Genes Dev. 2025 Apr 1;39(7-8):428-444. doi: 10.1101/gad.352306.124.
2
An exceptionally rare case of a diffuse midline glioma with concomitant H3.1 K27M and G34R mutations in the HIST1H3C (H3C3) gene.一例极为罕见的弥漫性中线胶质瘤病例,其HIST1H3C(H3C3)基因同时存在H3.1 K27M和G34R突变。
Acta Neuropathol Commun. 2025 Jan 16;13(1):7. doi: 10.1186/s40478-024-01899-5.
3
Inhibiting EZH2 targets atypical teratoid rhabdoid tumor by triggering viral mimicry via both RNA and DNA sensing pathways.
通过 RNA 和 DNA 感应途径触发病毒模拟,抑制 EZH2 靶点治疗非典型畸胎样横纹肌样瘤。
Nat Commun. 2024 Oct 29;15(1):9321. doi: 10.1038/s41467-024-53515-8.
4
Combination treatment with histone deacetylase and carbonic anhydrase 9 inhibitors shows therapeutic potential in experimental diffuse intrinsic pontine glioma.组蛋白去乙酰化酶和碳酸酐酶 9 抑制剂联合治疗在实验性弥漫性内在脑桥胶质瘤中有治疗潜力。
Brain Tumor Pathol. 2024 Oct;41(3-4):117-131. doi: 10.1007/s10014-024-00493-w. Epub 2024 Sep 24.
5
GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutant.γ-氨基丁酸能神经元谱系发育决定了弥漫性半球胶质瘤(H3G34突变型)中具有临床可操作性的靶点。
Cancer Cell. 2024 Aug 27. doi: 10.1016/j.ccell.2024.08.006.
6
A group 3 medulloblastoma stem cell program is maintained by OTX2-mediated alternative splicing.一组 3 型髓母细胞瘤干细胞程序由 OTX2 介导的选择性剪接维持。
Nat Cell Biol. 2024 Aug;26(8):1233-1246. doi: 10.1038/s41556-024-01460-5. Epub 2024 Jul 18.
7
DNA Damage and Chromatin Rearrangement Work Together to Promote Neurodegeneration.DNA损伤与染色质重排共同作用促进神经退行性变。
Mol Neurobiol. 2025 Jan;62(1):1282-1290. doi: 10.1007/s12035-024-04331-0. Epub 2024 Jul 8.
8
Group 3 medulloblastoma transcriptional networks collapse under domain specific EP300/CBP inhibition.3组髓母细胞瘤转录网络在结构域特异性EP300/CBP抑制作用下瓦解。
Nat Commun. 2024 Apr 25;15(1):3483. doi: 10.1038/s41467-024-47102-0.
9
Targeting Group 3 Medulloblastoma by the Anti-PRUNE-1 and Anti-LSD1/KDM1A Epigenetic Molecules.靶向第 3 组髓母细胞瘤的 PRUNE-1 和 LSD1/KDM1A 表观遗传分子。
Int J Mol Sci. 2024 Mar 31;25(7):3917. doi: 10.3390/ijms25073917.
10
Chromatin modifiers in human disease: from functional roles to regulatory mechanisms.染色质修饰物在人类疾病中的作用:从功能角色到调控机制。
Mol Biomed. 2024 Apr 8;5(1):12. doi: 10.1186/s43556-024-00175-1.